ALS Ltd (ALQ) - First-half softness

October 4, 2024

ALS provides professional technical services primarily in the areas of testing, measurement, and inspection in Africa, Asia/Pacific, Europe, the Middle East, and the Americas. It operates in two market segments, commodities and life sciences. ALS was founded in 1863 and is headquartered in Brisbane, Australia.

ALS warned that first-half FY25 underlying net profit would be down around 5% on a year ago, as volume declines, particularly in its Australian and Latin American operations, and higher finance costs squeezed margins for the commodity testing and life sciences group.

The company blamed the decline in volumes on several factors:

• Sluggish investment in mineral development in some Latin American countries due to political volatility;

• Weaker demand from China, the world’s largest commodity consumer; and

• Extended delays in clients raising capital before starting exploration on Australian projects

We maintain our Accumulate recommendation given the recent fall in share price, its exposure to an eventual rebound in commodity volumes as the global economy strengthens, and upside in the life sciences operations.

Insights that count

Discover the best opportunities to outperform the market. Our research team dig deep into the market, company and stock data to bring you insights others might overlook.

Whitehaven Coal (WHC) – Commodity tailwinds picking up

Whitehaven Coal develops and operates coal mines in Queensland and New South Wales. The company produces metallurgical and thermal coal.

Learn More

Ampol (ALD) – Refinery margin squeeze

Ampol is an independent Australian company involved in fuel marketing, refining, and convenience retail Ampol Limited was founded in 1900 and is headquartered in Alexandria, Australia.

Learn More

Qube Holdings (QUB) - Deal wheels keep turning

Qube Holdings provides logistics solutions for import and export supply chains in Australia, New Zealand, and Southeast Asia.

Learn More

Want to keep up to
date on our latest news & insights

Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.